v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024   184,264      
Beginning balance at Dec. 31, 2024 $ 1,795 $ 18 $ 88,773 $ (86,981) $ (15)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for services 60   60    
Stock-based compensation 118   118    
Foreign currency translation adjustment 28       28
Net loss (109)     (109)  
Ending balance (in shares) at Mar. 31, 2025   184,264      
Ending balance at Mar. 31, 2025 1,892 $ 18 88,951 (87,090) 13
Beginning balance (in shares) at Dec. 31, 2024   184,264      
Beginning balance at Dec. 31, 2024 1,795 $ 18 88,773 (86,981) (15)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment 68        
Net loss (370)        
Ending balance (in shares) at Jun. 30, 2025   184,264      
Ending balance at Jun. 30, 2025 1,803 $ 18 89,083 (87,351) 53
Beginning balance (in shares) at Mar. 31, 2025   184,264      
Beginning balance at Mar. 31, 2025 1,892 $ 18 88,951 (87,090) 13
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 132   132    
Foreign currency translation adjustment 40       40
Net loss (261)     (261)  
Ending balance (in shares) at Jun. 30, 2025   184,264      
Ending balance at Jun. 30, 2025 1,803 $ 18 89,083 (87,351) 53
Beginning balance (in shares) at Dec. 31, 2025   184,264      
Beginning balance at Dec. 31, 2025 1,468 $ 18 89,330 (87,939) 59
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from note conversion (in shares)   9,194      
Issuance of common stock from note conversion 552 $ 1 551    
Stock-based compensation 148   148    
Foreign currency translation adjustment (27)       (27)
Net loss (643)     (643)  
Ending balance (in shares) at Mar. 31, 2026   193,458      
Ending balance at Mar. 31, 2026 1,498 $ 19 90,029 (88,582) 32
Beginning balance (in shares) at Dec. 31, 2025   184,264      
Beginning balance at Dec. 31, 2025 1,468 $ 18 89,330 (87,939) 59
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment (33)        
Net loss (1,418)        
Ending balance (in shares) at Jun. 30, 2026   213,122      
Ending balance at Jun. 30, 2026 1,571 $ 21 90,881 (89,357) 26
Beginning balance (in shares) at Mar. 31, 2026   193,458      
Beginning balance at Mar. 31, 2026 1,498 $ 19 90,029 (88,582) 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from note conversion (in shares)   19,664      
Issuance of common stock from note conversion 706 $ 2 704    
Stock-based compensation 148   148    
Foreign currency translation adjustment (6)       (6)
Net loss (775)     (775)  
Ending balance (in shares) at Jun. 30, 2026   213,122      
Ending balance at Jun. 30, 2026 $ 1,571 $ 21 $ 90,881 $ (89,357) $ 26